WNTRX PHARMACEUTICALS INC has a total of 11 patent applications. Its first patent ever was published in 2016. It filed its patents most often in Canada, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are ONCOQUEST INC, PROTOX THERAPEUTICS INC and PLATELET TARGETED THERAPEUTICS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 2 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Zhu David | 11 |
#2 | Angell Yvonne | 5 |
#3 | Perni Robert | 5 |
Publication | Filing date | Title |
---|---|---|
CN111836632A | BCL9 peptides and variants thereof | |
AU2016336349A1 | Stabilized BCL9 peptides for treatment of aberrant Wnt signaling |